Australia Lactose Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Key Market Trends and Insights

• New South Wales dominated the Australia lactose market in 2025 and is projected to grow at a CAGR of 12.8% over the forecast period.
• By application, infant formula is expected to grow at a CAGR of 12.3% over the forecast period.
• By purity, the edible category is projected to witness a CAGR of 12.6% over the forecast period.

Market Size & Forecast

• Market Size in 2025: AUD 25.09 million
• Projected Market Size in 2035: AUD 72.54 million
• CAGR from 2026 to 2035: 11.20%
• Fastest-Growing Regional Market: New South Wales

The Australia lactose market growth is gaining momentum based on increased demand for high-purity lactose in the regulated industries. Manufacturers are demanding standardized dairy-derived excipients and other functional sugars as a requirement to maintain consistency, stability, and efficiency of the formulations. Innovation in technologies of whey processing and fractionation is also enhancing lactose yield and purity, and can be more readily incorporated into pharmaceutical, food, and infant nutrition uses. Meanwhile, the increasing application of lactose as a multifunctional carrier in oral solid dosage forms is strengthening its role in the pharmaceutical industry. These factors help to maintain the consistent expansion of the market by improving supply stability and expanding the range of applications in high-value industrial applications.

Lactose is commonly used as a filler and binder; it has outstanding compressibility, stability, and compatibility with active pharmaceutical ingredients and is an important ingredient in the making of the tablet. The rising demand for high-quality, stable excipients is driving suppliers to expand their product portfolios and strengthen distribution networks in regulated markets. This is also increasing the reliability of supply and efficiency of formulation for drug manufacturers in both developed and emerging areas. For instance, a notable development reinforcing this trend in the Australia lactose market is the partnership between LBB Specialties and Kerry Group, announced in April 2025, which expands access to Kerry’s Sheffield pharmaceutical lactose excipients, including anhydrous, spray-dried, and monohydrate grades for advanced drug formulation applications.

Recent Developments

July 2025 – FSANZ Approved Arla Foods Ingredients’ MFGM Ingredient for Infant Formula Use

Arla Foods Ingredients successfully obtained FSANZ approval for their MFGM ingredient in infant formula in Australia, allowing for more advanced formulations in early-life nutrition. The acceptance favors the Australia lactose market expansion since lactose remains a foundational carbohydrate in infant formula, providing energy and formulation stability.

March 2024 – Wellnex Life Partnered with Australian Dairy Nutritionals for Infant Formula Distribution in Australia

Wellnex Life collaborated with Australian Dairies Nutritionals and Ocean Road Dairies to deal with the sale of the infant formula through Chemist Warehouse. The growth facilitates the lactose industry expansion through the reinforcement of the large-scale production and retail supply, hence maintaining the demand for lactose in various areas of infant nutrition.

February 2024 – Australian Dairy Nutritionals Launched Ocean Road Dairies Organic A2 Infant Formula Supporting Lactose Utilisation

Australian Dairies Nutritionals introduced the Ocean Road Dairies organic A2 infant formula range, reinforcing its position as a high-end infant nutrition brand in Australia. The introduction enhances the overall Australia lactose market development as lactose is a key carbohydrate for energy and nutrient absorption in newborn formula, complementing further utilization in specialized dairy manufacturing and local product innovation.

October 2023 – Lactalis Ingredients Entered Pharmaceutical-Grade Lactose Segment with Lactalpha Range

Lactalis Ingredients started offering its Lactalpha range, a pharmaceutical-grade lactose solution line, in the high-purity excipient solutions segment. The development enhances the supply of pharmaceutical lactose as a binder and diluent in all tablets and capsules and boosts the demand throughout the pharmaceutical manufacturing applications.

Key Drivers and Trends

Investment in Dairy Infrastructure Strengthening Lactose Supply

The Australia lactose market is undergoing transformation on the supply-side as a result of increased investments in dairy farming and processing facilities to process lactose. Modernization and increased capacity of production are facilitating efficient processing of lactose for applications in food, pharmaceuticals, and infant nutrition. In line with this development, in May 2024, the Warakirri Asset Management announced an AUD 500 million dairy fund to enhance the dairy production ecosystem in Australia, indirectly ensuring a long-term supply of downstream lactose processing.

Expansion of Lactase Enzyme Technologies Driving Structural Growth in Lactose Processing Solutions

The increasing lactose intolerance is speeding up the uptake of lactase enzyme technologies, and it is transforming the overall Australia lactose market dynamics. Lactase enzymes are used to break down lactose molecules into glucose and galactose molecules, allowing lactose-free dairy to be produced without sacrificing nutrition or clear labeling. In October 2024, Kerry Group commented that lactose-free dairy is expected to be one of the fastest growing categories globally, owing to enzyme breakthroughs and acquisitions in the lactase solution space. This trend is driving dairy processors to invest in enzymatic technologies, which are having an indirect impact on lactose usage trends while also expanding the use of value-added dairy products in food and nutrition manufacturing systems. In December 2023, Kerry acquired a lactose-free enzyme technology business for EUR 150 million, strengthening its capabilities in producing lactose-free and reduced-sugar dairy products globally.

Advancements in Medical Nutrition Ingredients Driving Functional Dairy Innovation

The need to develop specialized medical nutrition formulations is prompting innovations in dairy-derived functional ingredients that, in turn, are boosting the overall Australia lactose market growth trajectory. Manufacturers are becoming increasingly interested in improving the protein delivery, taste, and digestibility of clinical nutrition products by using carefully regulated lactose-reduced or lactose-modified dairy fractions during processing. This trend is encouraging ingredient providers to optimize whey and milk fractionation technology for high-performance applications. In November 2024, the Arla Foods Ingredients Group P/S released Lacprodan DI-3092, a high-protein hydrolysate designed for use in medical nutrition with a better taste and low lactose characteristics, as part of its clinically targeted dairy ingredient development program.

Expansion of Dairy Product Innovation Supporting Steady Lactose Generation in Australia

Increasing innovation in the dairy product portfolio is facilitating further downstream use of lactose in the entire value chain, with manufacturers increasing production of butter, cream, cheese, and yogurt to satisfy the growing demand for luxury and convenience-driven dairy products. For instance, in August 2024, Fonterra Oceania introduced a series of new dairy items in Australia and New Zealand, such as snacking cheese, high-quality butter, and flavored spreads, given that consumers show a high demand for richer dairy experiences. While these expansions primarily drive innovation in finished dairy products, they also support consistent milk processing, indirectly sustaining lactose production as a natural byproduct in integrated dairy systems and boosting the Australia lactose market value.

Growing Demand for Clean-Label and Natural Dairy Alternatives in Australia

Consumer demand for clean-label, less processed dairy products is influencing product development strategies and the overall Australia lactose market trends and dynamics. Manufacturers are also shifting to enzyme-based lactose reduction techniques, which preserve the original flavor, texture, and nutritional value of dairy, increasing customer acceptance of lactose-managed products. This trend is increasing transparency in the sourcing and production processes, as well as confidence in branded products. Dairy firms have repackaged their portfolios to satisfy clean-label expectations, resulting in a long-term demand for naturally positioned, lactose-focused dairy innovations in retail and foodservice sectors.

Australia Lactose Market Share

By application, the pharmaceuticals category shows notable growth owing to the increasing utilization of pharma-grade lactose in drug formulations

The Australia lactose market is witnessing strong demand for high-purity excipients used in pharmaceutical drug manufacturing. Lactose is a popular binder and diluent in pills and capsules due to its stability, compressibility, and capacity to interact with active pharmaceutical ingredients. The need for pharmaceutical-grade lactose is increasing as pharmaceutical production grows and quality demands increase. For instance, in June 2023, Lactalis Ingredients debuted its Lactalpha line for the pharmaceutical lactose segment, reinforcing supply capacity.

The infant nutrition production in Australia is consolidating, with the production being more export-oriented. For example, in November 2024, the Australian brand Aiwibi, which is owned by ViPlus Dairy, launched a nourishing range of baby formula manufactured at the Toora factory in Victoria and shipped to Nepal. The development reflects dairy-based infant formula's reliance on lactose as a significant carbohydrate source in global supply chains. This trend has the potential to increase the utilization of local milk processing capacity and consolidate consistent demand in baby nutrition manufacturing, with the added benefit of long-term lactose use in the Australian dairy ingredient nexus.

By purity, crude lactose witnesses notable uptake owing to industrial-scale whey valorisation

The crude lactose segment is expanding as dairy processors focus on maximizing value from whey streams generated during cheese and casein production. Firms are now using crude lactose as a key ingredient for further refinement or for use in feed and industrial applications, hence increasing overall process efficiency and yield recovery. Large-scale dairy ingredient producers such as Lactalis Ingredients and Fonterra are maximizing whey valorization systems to ensure better utilization of lactose in processing by-products, thereby increasing the availability of crude lactose in downstream conversion to edible and pharmaceutical grade uses across the Australia lactose market value chain.

The refined edible lactose segment is also experiencing robust growth in the Australia lactose market, with the manufacturers focusing on high-purity-grade lactose as a pharmaceutical and infant food ingredient. To achieve consistent particle size and minimal contaminants, businesses are implementing contemporary purification techniques such as crystallization, ultrafiltration, and spray drying. Lactose producers like Kerry Group are focusing on selling pharmaceutical-grade lactose as a carrier and binder in tablets and supporting baby formula producers who require highly regulated sources of carbohydrates, which is driving the steady increase in demand for refined edible lactose in Australia.

Australia Lactose Market Regional Analysis

By region, New South Wales dominates the market, driven by innovation-led dairy biotechnology and a next-gen ingredient development hub

New South Wales is becoming a dairy ingredient innovation hub in the Australia lactose market as it is highly complemented by alliances between food-techs and biotechnology firms. Companies such as All G are exploring precision fermentation innovations to make animal-free dairy proteins, and firms in Sydney are testing lactose-based fermentation pathways for developing functional food products. These operations appear to be promising in terms of integrating traditional dairy processing with next-generation biomanufacturing in the region.

On the other hand, Victoria remains the leader in terms of dairy processing operations, with organizations, including Saputo Dairy Australia and Fonterra, having large-scale manufacturing units in the state. Such players are interested in integrated dairy production systems that produce not only cheese but also butter and infant nutrition products, ensuring a steady supply of whey as a consistent by-product. The recovered lactose is also utilized to make some of the ingredients that can be used and shipped to domestic and international markets; hence, Victoria is a strategic location that aids in maintaining a consistent supply and subsequent value-added manufacturing in the market.

Competitive Landscape

Major Australia lactose market players are focusing on integrated dairy processing methods that result in high lactose recovery from whey produced during cheese and protein manufacturing. Other companies, like Saputo Dairy Australia, Fonterra, and Lactalis Ingredients, are using novel separation, filtering, and drying methods to improve lactose yield and consistency. Another way these firms maximize co-product monetization is by converting whey streams into crude and edible lactose food, feed, and industrial products. The expansion of major processing plants and dairy production efficiency is allowing for increased lactose production, which has contributed to improve supply reliability and market growth in the future.

Leading Australia lactose companies are also directing their focus on product technology and purity improvement, while catering to the high-end applications such as pharmaceutical and infant nutrition. Many lactose companies, such as Kerry Group, are also producing refined lactose grades that have better functionalities in the formulation of tablets and infant formulas. Simultaneously, companies are extending the use of biological technologies into biotechnology and specialty nutrition, stabilizing demand and enabling higher-value opportunities within the market.

Key Players

Fonterra Co-Operative Group Limited

Fonterra Co-Operative Group Limited is a major dairy nutritional company, established in 2001 and headquartered in Auckland, New Zealand. The company has a significant dairy value chain and provides lactose and dairy products for food, pharmaceutical, and nutritional uses.

Lactalis Australia

Lactalis Australia is a prominent dairy processor that evolved alongside the global expansion of Lactalis Group, headquartered in Paris, France. The firm boasts of a prominent presence in the Australia lactose market with a comprehensive range of dairy products and marketable products.

FrieslandCampina Ingredients

FrieslandCampina Ingredients is a multinational dairy nutrition and ingredient solutions company that was established in 1871, and it is based in Amersfoort, the Netherlands. The company has specialized in the production of high-quality dairy-based ingredients such as lactose, used in the production of infant nutrition, medical nutrition, and functional food products.

Saputo Inc.

Saputo Inc. is a major dairy corporation that was established in 1954 and is based in Montreal, Canada. The company has a great presence throughout the globe with a heavy base in Australia, where it manufactures and distributes a wide variety of dairy products, such as lactose, using its well-integrated processing plants.

Other key players in the market include MaxumFoods, among others.

Key Highlights of the Australia Lactose Market Report

• Performance analysis with precise forecasting over the established projection period, to have a clear picture of the long-term Australia lactose market trend and patterns of growth.
• Reports on product innovation in crude, edible, and refined lactose products, as well as future developments in purification, whey processing, and lactose diversification in the food, pharmaceutical, and infant nutrition applications.
• Competitive profiling of the top domestic and global dairy ingredient manufacturers, strategies, capacity additions, and value chain integration.
• Regional analysis that determines the emerging growth centers in major Australian states because of dairy processing concentration, uptake of biotechnology, and export-based manufacturing systems.

Why Choose Expert Market Research?

• Reliable market insights supported by strong primary and secondary research in the Australia lactose market value chain.
• Practical data that can be used to make strategic decisions, strategic entry planning, and competitor benchmarking.
• Detailed geographical and product-based analysis that allows specific identification of growth prospects and trends in performance by the segment.

Call to Action

Explore the latest trends shaping the Australia lactose market 2026-2035 with our in-depth report. Gain strategic insights, future forecasts, and key market developments that can help you stay competitive. Download a free sample report or contact our team for customized consultation on the Australia lactose market trends 2026.